Eve Jelstrom

Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial

Yih‐Ing Hser, Elizabeth Evans, David Huang et al. · Addiction · 2015 · 216 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care

Jan Gryczynski, Jennifer McNeely, Li‐Tzy Wu et al. · Journal of General Internal Medicine · 2017 · 78 citations · Full text

Nursing, Health Promotion, Primary Care +11

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

P. Todd Korthuis, Ryan Cook, Paula J. Lum et al. · Addiction · 2022 · 24 citations · Full text

Nursing, Clinical Pharmacy, Pharmacotherapy +15

PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high

Mary A. Hatch, Tanja C. Laschober, Margaret M. Paschen-Wolff et al. · Drug and Alcohol Dependence · 2024 · 14 citations · Full text

Public Health, Community Health, Preventive Medicine +14

Use of single IRBs for multi-site studies: A case report and commentary from a National Drug Abuse Treatment Clinical Trials Network study

Ceilidh Nichols, Lynn E. Kunkel, Robin Baker et al. · Contemporary Clinical Trials Communications · 2019 · 13 citations · Full text

Law, Health Policy, Clinical Pharmacology +15